Similar articles

• [GM-CSF: its clinical administration; the treatment of aplasia].

  Rossi Ferrini P, Grossi A, Santini V, Vannucchi AM. Rossi Ferrini P, et al. Haematologica. 1989 Oct;74(5 Suppl):489-500. Haematologica. 1989. PMID: 2512231 Review. Italian. No abstract available.
• Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials.

  Nissen-Druey C. Nissen-Druey C. Nouv Rev Fr Hematol (1978). 1989;31(2):99-101. Nouv Rev Fr Hematol (1978). 1989. PMID: 2475852 Review. No abstract available.
• Clinical role of granulocyte-macrophage colony-stimulating factor.

  Mitsuyasu RT, Golde DW. Mitsuyasu RT, et al. Hematol Oncol Clin North Am. 1989 Sep;3(3):411-25. Hematol Oncol Clin North Am. 1989. PMID: 2698875 Review.
• Target cells for GM-CSF and kinetics of response.

  Aglietta M, Bussolino F, Piacibello W, Aprá F, Sanavio F, Stacchini A, Monzeglio C, Carnino F, Stern AC, Gavosto F. Aglietta M, et al. Prog Clin Biol Res. 1990;352:519-30. Prog Clin Biol Res. 1990. PMID: 2169636 Review. No abstract available.
• Granulocyte colony-stimulating factor: preclinical and clinical studies.

  Gabrilove JL, Jakubowski A. Gabrilove JL, et al. Hematol Oncol Clin North Am. 1989 Sep;3(3):427-40. Hematol Oncol Clin North Am. 1989. PMID: 2483722 Review.